These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17892078)

  • 1. Evaluating follow-up of positive fecal occult blood test results: lessons learned.
    Chen ZJ; Kammer D; Bond JH; Ho SB
    J Healthc Qual; 2007; 29(5):16-20, 34. PubMed ID: 17892078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the effectiveness of fecal occult blood testing in a primary care clinic by direct colonoscopy referral for positive tests.
    Van Kleek E; Liu S; Conn LM; Hoadley A; Ho SB
    J Healthc Qual; 2010; 32(6):62-9. PubMed ID: 20946427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organizational predictors of colonoscopy follow-up for positive fecal occult blood test results: an observational study.
    Partin MR; Burgess DJ; Burgess JF; Gravely A; Haggstrom D; Lillie SE; Nugent S; Powell AA; Shaukat A; Walter LC; Nelson DB
    Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):422-34. PubMed ID: 25471345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mailed participant reminders are associated with improved colonoscopy uptake after a positive FOBT result in Ontario's ColonCancerCheck program.
    Stock D; Rabeneck L; Baxter NN; Paszat LF; Sutradhar R; Yun L; Tinmouth J
    Implement Sci; 2015 Mar; 10():35. PubMed ID: 25885531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An audit of the utility of in-patient fecal occult blood testing.
    Sharma VK; Komanduri S; Nayyar S; Headly A; Modlinger P; Metz DC; Verghese VJ; Wanahita A; Go MF; Howden CW
    Am J Gastroenterol; 2001 Apr; 96(4):1256-60. PubMed ID: 11316179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reasons For Lack of Follow-up Colonoscopy Among Persons With A Positive Fecal Occult Blood Test Result: A Qualitative Study.
    Llovet D; Serenity M; Conn LG; Bravo CA; McCurdy BR; Dubé C; Baxter NN; Paszat L; Rabeneck L; Peters A; Tinmouth J
    Am J Gastroenterol; 2018 Dec; 113(12):1872-1880. PubMed ID: 30361625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A national survey of primary care physicians' methods for screening for fecal occult blood.
    Nadel MR; Shapiro JA; Klabunde CN; Seeff LC; Uhler R; Smith RA; Ransohoff DF
    Ann Intern Med; 2005 Jan; 142(2):86-94. PubMed ID: 15657156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fecal occult blood test as a tool for improved outpatient qualification for colonoscopy. A single-center experience and 10-year follow-up survey.
    Banaszkiewicz Z; Budzyński J; Tojek K; Jarmocik P; Frasz J; Mrozowski M; Świtoński M; Jawień A
    Adv Med Sci; 2017 Mar; 62(1):171-176. PubMed ID: 28282604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.
    Baig N; Myers RE; Turner BJ; Grana J; Rothermel T; Schlackman N; Weinberg DS
    Am J Gastroenterol; 2003 Sep; 98(9):2078-81. PubMed ID: 14499791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic follow-up of positive fecal occult blood testing in the Ontario FOBT Project.
    Paszat L; Rabeneck L; Kiefer L; Mai V; Ritvo P; Sullivan T
    Can J Gastroenterol; 2007 Jun; 21(6):379-82. PubMed ID: 17571172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of colorectal diseases in immunological fecal occult blood test (I-FOBT) positive patients in a tertiary care hospital in Bangladesh.
    Mollick SH; Roy PK; Bhuiyan MR; Mia AR; Alam MS; Mollick KA; Pervin S; Hassan MQ
    Mymensingh Med J; 2014 Oct; 23(4):764-9. PubMed ID: 25481598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic testing following fecal occult blood screening in the elderly.
    Lurie JD; Welch HG
    J Natl Cancer Inst; 1999 Oct; 91(19):1641-6. PubMed ID: 10511591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance.
    Vijan S; Hwang EW; Hofer TP; Hayward RA
    Am J Med; 2001 Dec; 111(8):593-601. PubMed ID: 11755501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time from positive screening fecal occult blood test to colonoscopy and risk of neoplasia.
    Gellad ZF; Almirall D; Provenzale D; Fisher DA
    Dig Dis Sci; 2009 Nov; 54(11):2497-502. PubMed ID: 19093199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.
    Partin MR; Gravely AA; Burgess JF; Haggstrom DA; Lillie SE; Nelson DB; Nugent SM; Shaukat A; Sultan S; Walter LC; Burgess DJ
    Cancer; 2017 Sep; 123(18):3502-3512. PubMed ID: 28493543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of participation in faecal occult blood testing and screening colonoscopy after health education in Hong Kong.
    Wong BC; Chan AO; Wong KW; Ching CK; Wong WM; Tam S; Lai KC; Chan CK; Yuen MF; Lam SK
    Eur J Cancer Prev; 2005 Apr; 14(2):181-4. PubMed ID: 15785323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early detection of bowel cancer in occupational surveillance examinations: switching from a guaiak-based to an immunochemical fecal occult blood test].
    Webendörfer S; Riemann JF
    Dtsch Med Wochenschr; 2014 Jan; 139(3):79-83. PubMed ID: 24089288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inappropriate colorectal cancer screening: findings and implications.
    Fisher DA; Judd L; Sanford NS
    Am J Gastroenterol; 2005 Nov; 100(11):2526-30. PubMed ID: 16279910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient preferences for colorectal cancer screening: how does stool DNA testing fare?
    Schroy PC; Lal S; Glick JT; Robinson PA; Zamor P; Heeren TC
    Am J Manag Care; 2007 Jul; 13(7):393-400. PubMed ID: 17620034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.